Skip Navigation
Skip Website Tools

Contact Info

Beth Spinelli (Interventional Agents)
Project Officer, Drug Development Section
Office of Biodefense Research Affairs
spinellb@niaid.nih.gov

Raymond Harris (Biopharmaceutical Products)
Program Officer
Office of Biodefense Research Affairs
harrisr2@niaid.nih.gov

Microbiology and Infectious Diseases Resources

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Therapeutic Development Services

The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins, including

  • Interventional Agents—therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents.
  • Biopharmaceutical Products—therapeutics that are derived from biotechnology processes, such as monoclonal antibodies and derivatives of monoclonal antibodies; recombinant proteins; peptides; nucleic acid based vectors (siRNA, plasmids); and live, modified-live and/or attenuated entities.

Last Updated March 05, 2014